Cargando…

Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma

Rad51, a DNA-repair-related gene, has been reported to be involved in multiple cancers. However, its link with immune infiltration in liver cancer still unknown. Therefore, more research into the roles and activities of Rad51 in hepatocellular carcinoma (HCC) is required. The International Cancer Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hao, Xiong, Chen, Chen, Yuan, Zhang, Chi, Bai, Dousheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806544/
https://www.ncbi.nlm.nih.gov/pubmed/34115569
http://dx.doi.org/10.1080/21655979.2021.1938470
_version_ 1784643473808293888
author Xu, Hao
Xiong, Chen
Chen, Yuan
Zhang, Chi
Bai, Dousheng
author_facet Xu, Hao
Xiong, Chen
Chen, Yuan
Zhang, Chi
Bai, Dousheng
author_sort Xu, Hao
collection PubMed
description Rad51, a DNA-repair-related gene, has been reported to be involved in multiple cancers. However, its link with immune infiltration in liver cancer still unknown. Therefore, more research into the roles and activities of Rad51 in hepatocellular carcinoma (HCC) is required. The International Cancer Genome Consortium (ICGC) was used to identify the DNA repair gene Rad51, and has been proved to be overexpressed in HCC patients. We plotted the Kapan-Meier curve, demonstrating that patients with high expression of Rad51 have a poor prognosis. By analyzing the patient data, we discovered that high expression of Rad51 in HCC is linked to clinical stage, pathological T stage, grade, and age. Rad51 was found to be an independent prognostic factor for HCC patients using the multivariate cox model. Moreover, Rad51 expression was found to be associated with the infiltration of immune cells (B cells, CD4 + T cells, CD8 + T cells, neutrophils, macrophages, and dendritic cells) and was intimately linked to the expression of immune cell markers in HCC. Through the analysis of differentially coexpressed genes (DCGs) of Rad51, GO and KEGG enrichment analyses suggested that the expression level of Rad51 might be relevant to neuroactive ligand-receptor interactions, the cell cycle, DNA replication, homologous recombination, oocyte meiosis, and the Fanconi anemia pathway. These findings indicated that Rad51 is a valuable biomarker for the prognosis of patients with liver cancer and that its expression has a significant correlation with immune infiltrations. Abbreviations: HCC: hepatocellular carcinoma; ICGC: International Cancer Genome Consortium TCGA: The Cancer Genome Atlas; TIMER: Tumor Immune Estimation Resource; CAF: Cancer-associated fibroblast; GEPIA: Gene Expression Profiling Interactive Analysis; GSEA: Gene set enrichment analysis; OS: overall survival; PFS: progression-free survival; RFS: relapse-free survival; DSS: disease-specific survival. Partial cor: partial correlation coefficient; HPA: Human Protein Atlas; GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; CAF: Cancer-associated fibroblast; DCGs: differentially co-expressed genes
format Online
Article
Text
id pubmed-8806544
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88065442022-02-02 Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma Xu, Hao Xiong, Chen Chen, Yuan Zhang, Chi Bai, Dousheng Bioengineered Research Paper Rad51, a DNA-repair-related gene, has been reported to be involved in multiple cancers. However, its link with immune infiltration in liver cancer still unknown. Therefore, more research into the roles and activities of Rad51 in hepatocellular carcinoma (HCC) is required. The International Cancer Genome Consortium (ICGC) was used to identify the DNA repair gene Rad51, and has been proved to be overexpressed in HCC patients. We plotted the Kapan-Meier curve, demonstrating that patients with high expression of Rad51 have a poor prognosis. By analyzing the patient data, we discovered that high expression of Rad51 in HCC is linked to clinical stage, pathological T stage, grade, and age. Rad51 was found to be an independent prognostic factor for HCC patients using the multivariate cox model. Moreover, Rad51 expression was found to be associated with the infiltration of immune cells (B cells, CD4 + T cells, CD8 + T cells, neutrophils, macrophages, and dendritic cells) and was intimately linked to the expression of immune cell markers in HCC. Through the analysis of differentially coexpressed genes (DCGs) of Rad51, GO and KEGG enrichment analyses suggested that the expression level of Rad51 might be relevant to neuroactive ligand-receptor interactions, the cell cycle, DNA replication, homologous recombination, oocyte meiosis, and the Fanconi anemia pathway. These findings indicated that Rad51 is a valuable biomarker for the prognosis of patients with liver cancer and that its expression has a significant correlation with immune infiltrations. Abbreviations: HCC: hepatocellular carcinoma; ICGC: International Cancer Genome Consortium TCGA: The Cancer Genome Atlas; TIMER: Tumor Immune Estimation Resource; CAF: Cancer-associated fibroblast; GEPIA: Gene Expression Profiling Interactive Analysis; GSEA: Gene set enrichment analysis; OS: overall survival; PFS: progression-free survival; RFS: relapse-free survival; DSS: disease-specific survival. Partial cor: partial correlation coefficient; HPA: Human Protein Atlas; GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; CAF: Cancer-associated fibroblast; DCGs: differentially co-expressed genes Taylor & Francis 2021-06-11 /pmc/articles/PMC8806544/ /pubmed/34115569 http://dx.doi.org/10.1080/21655979.2021.1938470 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Xu, Hao
Xiong, Chen
Chen, Yuan
Zhang, Chi
Bai, Dousheng
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
title Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
title_full Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
title_fullStr Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
title_full_unstemmed Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
title_short Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
title_sort identification of rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806544/
https://www.ncbi.nlm.nih.gov/pubmed/34115569
http://dx.doi.org/10.1080/21655979.2021.1938470
work_keys_str_mv AT xuhao identificationofrad51asaprognosticbiomarkercorrelatedwithimmuneinfiltrationinhepatocellularcarcinoma
AT xiongchen identificationofrad51asaprognosticbiomarkercorrelatedwithimmuneinfiltrationinhepatocellularcarcinoma
AT chenyuan identificationofrad51asaprognosticbiomarkercorrelatedwithimmuneinfiltrationinhepatocellularcarcinoma
AT zhangchi identificationofrad51asaprognosticbiomarkercorrelatedwithimmuneinfiltrationinhepatocellularcarcinoma
AT baidousheng identificationofrad51asaprognosticbiomarkercorrelatedwithimmuneinfiltrationinhepatocellularcarcinoma